Insight

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Insight

After TKI , adding Pembro to chemo DOES NOT improve OS – Rami Manochakian

Photo: Rami Manochakian/ASCO

Jun 7, 2023, 10:31

After TKI , adding Pembro to chemo DOES NOT improve OS – Rami Manochakian

NEGATIVE results of Keynote789 trial:

Platinum + Pem +/- Pembro for TKI-resistant EGFR mutant NSCLC

❌PFS HR 0.8, P=0.0122
mPFS: 5.6 vs 5.5 mths

❌OS HR 0.84, P=0.0362
mOS: 15.9 vs 14.7 mths

After TKI , adding Pembro to chemo DOES NOT improve OS

Source: Rami Manochakian / Twitter

ASCO2023 Keynote789 Pembro Rami Manochakian TKI

Jul 26, 2024, 03:32

Ashley Schreier has been awarded the Twisted Pink Metastatic Breast Cancer Impact Award - Conquer Cancer, the ASCO Foundation

Jul 26, 2024, 03:26

Exercise and biomarkers of early-stage prostate cancer - MSKCC

Jul 26, 2024, 03:16

Ruzanna Papyan: Educational Session at the Global Neuroblastoma Network

Jul 26, 2024, 03:05

Discussion on management of early-stage disease - IASLC

Jul 26, 2024, 01:42

Recordings from 2024 Pan-Tumour Biomarkers Conference are available

Jul 26, 2024, 00:49

SIU-Urology - Participate in the 6th B2B GU Cancers Triad Meeting

Jul 26, 2024, 00:38

Florez Lab - Unique challenges women face in lung cancer care

Jul 26, 2024, 00:27

Stephen V Liu: Rapid communication on management of stage III NSCLC by ASCO

Jul 26, 2024, 00:19

Expansion of LUNGevity Foundation's Board of Directors

Jul 26, 2024, 00:18

Sara Tolaney on novel therapies for young women with breast cancer at Young Women's Forum

Jul 26, 2024, 00:18

Erika Hamilton: Join us in Nashville for updates in Women's Oncology

Jul 26, 2024, 00:17

Anand Patel: Analysis of intensive chemotherapy in CBF-AML